908 Devices (NASDAQ:MASS) Earns "Sell (E+)" Rating from Weiss Ratings

908 Devices (NASDAQ:MASS - Get Free Report)'s stock had its "sell (e+)" rating restated by stock analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Several other analysts have also issued reports on the stock. Leerink Partnrs lowered shares of 908 Devices from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, November 13th. Stifel Nicolaus lowered their price objective on 908 Devices from $17.00 to $6.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Leerink Partners reissued a "market perform" rating and set a $4.00 target price (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Finally, Stephens reaffirmed an "overweight" rating and issued a $6.00 price target on shares of 908 Devices in a research note on Wednesday, January 15th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $5.33.

908 Devices Stock Down 6.8 %

Shares of MASS stock traded down $0.19 during trading hours on Wednesday, hitting $2.54. 195,428 shares of the company's stock were exchanged, compared to its average volume of 288,248. 908 Devices has a fifty-two week low of $1.81 and a fifty-two week high of $7.91. The firm has a market cap of $88.27 million, a P/E ratio of -1.43 and a beta of 0.99. The firm has a 50 day moving average of $2.39 and a two-hundred day moving average of $3.05.

Institutional Trading of 908 Devices

A number of hedge funds have recently bought and sold shares of MASS. AWM Investment Company Inc. boosted its holdings in shares of 908 Devices by 6.3% during the 4th quarter. AWM Investment Company Inc. now owns 1,673,924 shares of the company's stock worth $3,683,000 after purchasing an additional 99,594 shares during the last quarter. Geode Capital Management LLC boosted its stake in 908 Devices by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 581,300 shares of the company's stock worth $1,279,000 after buying an additional 13,512 shares during the last quarter. State Street Corp grew its holdings in 908 Devices by 1.2% in the 3rd quarter. State Street Corp now owns 479,044 shares of the company's stock valued at $1,662,000 after buying an additional 5,704 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of 908 Devices by 14.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 220,477 shares of the company's stock worth $765,000 after acquiring an additional 28,015 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in shares of 908 Devices by 7.5% during the 4th quarter. Northern Trust Corp now owns 200,764 shares of the company's stock worth $442,000 after acquiring an additional 14,087 shares during the period. Institutional investors and hedge funds own 88.06% of the company's stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.